The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 41, Issue 12, Pages 2818-2829
Publisher
Springer Nature
Online
2016-04-25
DOI
10.1038/npp.2016.61
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress
- (2015) John R Mantsch et al. NEUROPSYCHOPHARMACOLOGY
- Methods for inducing alcohol craving in individuals with co-morbid alcohol dependence and posttraumatic stress disorder: behavioral and physiological outcomes
- (2014) Laura E. Kwako et al. ADDICTION BIOLOGY
- The CRH1 Antagonist GSK561679 Increases Human Fear But Not Anxiety as Assessed by Startle
- (2014) Christian Grillon et al. NEUROPSYCHOPHARMACOLOGY
- The Corticotropin Releasing Hormone-1 (CRH1) Receptor Antagonist Pexacerfont in Alcohol Dependence: A Randomized Controlled Experimental Medicine Study
- (2014) Laura E Kwako et al. NEUROPSYCHOPHARMACOLOGY
- Behavioral, biological, and chemical perspectives on targeting CRF1 receptor antagonists to treat alcoholism
- (2013) Eric P. Zorrilla et al. DRUG AND ALCOHOL DEPENDENCE
- Determining target engagement in living systems
- (2013) Gabriel M Simon et al. Nature Chemical Biology
- Medications development to treat alcohol dependence: a vision for the next decade
- (2012) Raye Z. Litten et al. ADDICTION BIOLOGY
- Prazosin Effects on Stress- and Cue-Induced Craving and Stress Response in Alcohol-Dependent Individuals: Preliminary Findings
- (2011) Helen C. Fox et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Effects of Adrenal Sensitivity, Stress- and Cue-Induced Craving, and Anxiety on Subsequent Alcohol Relapse and Treatment Outcomes
- (2011) Rajita Sinha ARCHIVES OF GENERAL PSYCHIATRY
- Pharmacogenetic approaches to the treatment of alcohol addiction
- (2011) Markus Heilig et al. NATURE REVIEWS NEUROSCIENCE
- Translational and reverse translational research on the role of stress in drug craving and relapse
- (2011) Rajita Sinha et al. PSYCHOPHARMACOLOGY
- Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties
- (2010) John E. Tellew et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder
- (2010) Vladimir Coric et al. DEPRESSION AND ANXIETY
- Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF1) Antagonists
- (2009) Paul J. Gilligan et al. JOURNAL OF MEDICINAL CHEMISTRY
- A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1Antagonist) in the Treatment of Major Depression
- (2008) Brendon Binneman et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism
- (2008) D. T. George et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started